Staidson (Beijing) BioPharmaceuticals Co., Ltd. 300204.SZ Stock
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Price Chart
Staidson (Beijing) BioPharmaceuticals Co., Ltd. 300204.SZ Financial and Trading Overview
Contents
- Staidson (Beijing) BioPharmaceuticals Co., Ltd. Price Chart
- Staidson (Beijing) BioPharmaceuticals Co., Ltd. 300204.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Staidson (Beijing) BioPharmaceuticals Co., Ltd.
- Q&A For Staidson (Beijing) BioPharmaceuticals Co., Ltd. Stock
| Staidson (Beijing) BioPharmaceuticals Co., Ltd. stock price | 6.07 CNY |
| Previous Close | 10.34 CNY |
| Open | 10.33 CNY |
| Bid | 10.35 CNY x 0 |
| Ask | 10.36 CNY x 0 |
| Day's Range | 10.31 - 10.45 CNY |
| 52 Week Range | 9.52 - 19.5 CNY |
| Volume | 3.62M CNY |
| Avg. Volume | 12.07M CNY |
| Market Cap | 4.92B CNY |
| Beta (5Y Monthly) | 0.430136 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.84 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 17, 2019 |
| 1y Target Est | N/A |
300204.SZ Valuation Measures
| Enterprise Value | 4.71B CNY |
| Trailing P/E | N/A |
| Forward P/E | 13.454545 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.036803 |
| Price/Book (mrq) | 3.8613489 |
| Enterprise Value/Revenue | 9.596 |
| Enterprise Value/EBITDA | -20.661 |
Trading Information
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.430136 |
| 52-Week Change | -16.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.5 CNY |
| 52 Week Low | 9.52 CNY |
| 50-Day Moving Average | 11.07 CNY |
| 200-Day Moving Average | 12.07 CNY |
300204.SZ Share Statistics
| Avg. Volume (3 month) | 12.07M CNY |
| Avg. Daily Volume (10-Days) | 4.74M CNY |
| Shares Outstanding | 475.36M |
| Float | 250.2M |
| Short Ratio | N/A |
| % Held by Insiders | 48.69% |
| % Held by Institutions | 5.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 13.99594:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -45.10% |
| Operating Margin (ttm) | -52.60% |
| Gross Margin | 82.88% |
| EBITDA Margin | -46.44% |
Management Effectiveness
| Return on Assets (ttm) | -9.84% |
| Return on Equity (ttm) | -16.079% |
Income Statement
| Revenue (ttm) | 490.67M CNY |
| Revenue Per Share (ttm) | 1.02 CNY |
| Quarterly Revenue Growth (yoy) | -47.29% |
| Gross Profit (ttm) | 447.22M CNY |
| EBITDA | -227883360 CNY |
| Net Income Avi to Common (ttm) | -221323648 CNY |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 212.01M CNY |
| Total Cash Per Share (mrq) | 0.45 CNY |
| Total Debt (mrq) | 5.14M CNY |
| Total Debt/Equity (mrq) | 0.4 CNY |
| Current Ratio (mrq) | 2.449 |
| Book Value Per Share (mrq) | 2.683 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -187406432 CNY |
| Levered Free Cash Flow (ttm) | -151788976 CNY |
Profile of Staidson (Beijing) BioPharmaceuticals Co., Ltd.
| Country | China |
| State | N/A |
| City | Beijing |
| Address | No. 36, Jinghai Er Road |
| ZIP | 100176 |
| Phone | 86 10 6751 9888 |
| Website | https://www.staidson.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 803 |
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Q&A For Staidson (Beijing) BioPharmaceuticals Co., Ltd. Stock
What is a current 300204.SZ stock price?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. 300204.SZ stock price today per share is 6.07 CNY.
How to purchase Staidson (Beijing) BioPharmaceuticals Co., Ltd. stock?
You can buy 300204.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Staidson (Beijing) BioPharmaceuticals Co., Ltd.?
The stock symbol or ticker of Staidson (Beijing) BioPharmaceuticals Co., Ltd. is 300204.SZ.
Which industry does the Staidson (Beijing) BioPharmaceuticals Co., Ltd. company belong to?
The Staidson (Beijing) BioPharmaceuticals Co., Ltd. industry is Biotechnology.
How many shares does Staidson (Beijing) BioPharmaceuticals Co., Ltd. have in circulation?
The max supply of Staidson (Beijing) BioPharmaceuticals Co., Ltd. shares is 477.77M.
What is Staidson (Beijing) BioPharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. PE Ratio is now.
What was Staidson (Beijing) BioPharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. EPS is -0.84 CNY over the trailing 12 months.
Which sector does the Staidson (Beijing) BioPharmaceuticals Co., Ltd. company belong to?
The Staidson (Beijing) BioPharmaceuticals Co., Ltd. sector is Healthcare.